Ventyx Biosciences, Inc.
VTYX
$1.20
-$0.06-4.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -4.11% | 0.20% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.91% | 7.95% | |||
| Operating Income | 15.91% | -7.95% | |||
| Income Before Tax | 16.73% | -10.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 16.73% | -10.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.73% | -10.33% | |||
| EBIT | 15.91% | -7.95% | |||
| EBITDA | 15.94% | -7.96% | |||
| EPS Basic | 16.90% | -10.16% | |||
| Normalized Basic EPS | 16.90% | -10.18% | |||
| EPS Diluted | 16.90% | -10.16% | |||
| Normalized Diluted EPS | 16.90% | -10.18% | |||
| Average Basic Shares Outstanding | 0.20% | 0.16% | |||
| Average Diluted Shares Outstanding | 0.20% | 0.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||